Advertisement

Topics

NephroGenex, Inc. Company Profile

03:27 EST 21st November 2017 | BioPortfolio

NephroGenex (www.nephrogenex.com) is a drug development company focusing on kidney disease. More than 20 million Americans have some form of chronic kidney disease, and over 400,000 in the US have end stage renal disease requiring dialysis, making renal disease one of the costliest illnesses to treat. The Company is developing Pyridorin(TM) (pyridoxamine dihydrochloride) as a treatment to slow the progression of diabetic kidney disease. Pyridorin(TM) has demonstrated a significant treatment effect in slowing the progression of diabetic nephropathy in two Phase IIa clinical trials, and has been awarded Fast Track status by the FDA. Pyridorin(TM) is one of only a few drug candidates in advanced clinical trials for diabetic kidney disease, and possesses a distinctly new mechanism of action over currently approved treatments. NephroGenex will seek a partner for Phase III development and commercialization.


News Articles [3 Associated News Articles listed on BioPortfolio]

Financial Review: NephroGenex

NephroGenex and Mylan N.V. are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional...

NephroGenex Inc NRXGQ Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

SummaryNephroGenex Inc NephroGenex is a pharmaceutical company that offers development of drugs to treat kidney diseases. The company offers pyridorin is a novel acting compound used to improve treatm...

NephroGenex Inc NRXGQ Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13092017] Prices from USD $250

SummaryNephroGenex Inc NephroGenex is a pharmaceutical company that offers development of drugs to treat kidney diseases. The company offers pyridorin is a novel acting compound used to improve treatm...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

NephroGenex, Inc.

NephroGenex (www.nephrogenex.com) is a drug development company focusing on kidney disease. More than 20 million Americans have some form of chronic kidney disease, and over 400,000 in the US have en...

More Information about "NephroGenex, Inc." on BioPortfolio

We have published hundreds of NephroGenex, Inc. news stories on BioPortfolio along with dozens of NephroGenex, Inc. Clinical Trials and PubMed Articles about NephroGenex, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NephroGenex, Inc. Companies in our database. You can also find out about relevant NephroGenex, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...


Corporate Database Quicklinks



Searches Linking to this Company Record